Metropolitan Life Insurance Company (MetLife)’s Revvity RVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,976
Closed -$522K 1712
2024
Q1
$522K Sell
4,976
-46
-0.9% -$4.89K 0.02% 467
2023
Q4
$549K Sell
5,022
-113
-2% -$10.9K 0.03% 448
2023
Q3
$568K Sell
5,135
-331
-6% -$38.9K 0.03% 419
2023
Q2
$649K Sell
5,466
-183
-3% -$22.5K 0.03% 408
2023
Q1
$753K Sell
5,649
-1,650
-23% -$217K 0.04% 382
2022
Q4
$1.02M Buy
7,299
+52
+0.7% +$7K 0.05% 364
2022
Q3
$872K Sell
7,247
-85
-1% -$12K 0.04% 382
2022
Q2
$1.04M Sell
7,332
-191
-3% -$28.6K 0.05% 356
2022
Q1
$1.31M Sell
7,523
-6,635
-47% -$1.18M 0.05% 348
2021
Q4
$2.85M Buy
14,158
+1,220
+9% +$221K 0.04% 381
2021
Q3
$2.24M Sell
12,938
-445
-3% -$78.4K 0.03% 455
2021
Q2
$2.07M Sell
13,383
-1,295
-9% -$182K 0.03% 514
2021
Q1
$1.88M Sell
14,678
-755
-5% -$105K 0.03% 548
2020
Q4
$2.21M Sell
15,433
-861
-5% -$115K 0.03% 439
2020
Q3
$2.05M Sell
16,294
-660
-4% -$75.9K 0.03% 408
2020
Q2
$1.66M Sell
16,954
-762
-4% -$69.7K 0.03% 472
2020
Q1
$1.33M Sell
17,716
-119
-0.7% -$10.6K 0.03% 545
2019
Q4
$1.73M Sell
17,835
-8
-0% -$714 0.03% 613
2019
Q3
$1.52M Buy
17,843
+1,279
+8% +$112K 0.03% 639
2019
Q2
$1.6M Buy
16,564
+1,199
+8% +$112K 0.03% 633
2019
Q1
$1.48M Sell
15,365
-604
-4% -$54.4K 0.03% 647
2018
Q4
$1.25M Buy
15,969
+36
+0.2% +$3.04K 0.03% 673
2018
Q3
$1.55M Sell
15,933
-592
-4% -$50.9K 0.03% 672
2018
Q2
$1.21M Sell
16,525
-1,419
-8% -$106K 0.02% 823
2018
Q1
$1.36M Buy
17,944
+139
+0.8% +$10.7K 0.02% 747
2017
Q4
$1.3M Sell
17,805
-35,447
-67% -$2.54M 0.02% 777
2017
Q3
$3.67M Sell
53,252
-1,006
-2% -$67.5K 0.02% 736
2017
Q2
$3.7M Sell
54,258
-1,267
-2% -$78.7K 0.03% 725
2017
Q1
$3.22M Sell
55,525
-732
-1% -$39.9K 0.02% 795
2016
Q4
$2.93M Sell
56,257
-750
-1% -$39.2K 0.02% 824
2016
Q3
$3.2M Sell
57,007
-299
-0.5% -$16.3K 0.02% 766
2016
Q2
$3M Sell
57,306
-834
-1% -$43.8K 0.02% 772
2016
Q1
$2.88M Sell
58,140
-1,911
-3% -$91.3K 0.02% 767
2015
Q4
$3.22M Sell
60,051
-2,140
-3% -$109K 0.02% 698
2015
Q3
$2.86M Sell
62,191
-1,031
-2% -$51.2K 0.02% 758
2015
Q2
$3.33M Sell
63,222
-172
-0.3% -$8.97K 0.02% 746
2015
Q1
$3.24M Sell
63,394
-794
-1% -$36.8K 0.02% 712
2014
Q4
$2.81M Sell
64,188
-511
-0.8% -$22K 0.02% 818
2014
Q3
$2.82M Sell
64,699
-1,134
-2% -$51.6K 0.02% 789
2014
Q2
$3.08M Sell
65,833
-2,087
-3% -$93.7K 0.02% 788
2014
Q1
$3.06M Sell
67,920
-812
-1% -$35.6K 0.02% 775
2013
Q4
$2.83M Sell
68,732
-394
-0.6% -$15.1K 0.02% 793
2013
Q3
$2.61M Sell
69,126
-325
-0.5% -$11.7K 0.02% 793
2013
Q2
$2.26M Buy
+69,451
New +$2.27M 0.02% 820

Other funds holding RVTY

Metropolitan Life Insurance Company (MetLife)'s RVTY Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Revvity (RVTY) in Q2 2024, closing a stake of 4,976 shares — an estimated $522K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RVTY in Q2 2013 and held it in 44 quarters. The position peaked at $3.7M in Q2 2017. 484 funds tracked by Wall St. Rank hold RVTY as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Revvity position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,976 Revvity shares in Q2 2024, an estimated $522K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Revvity in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Revvity position peaked at $3.7M in Q2 2017.
  • 484 funds tracked by Wall St. Rank held Revvity as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.